US Patent Issued to SHENZHEN PROFOUND VIEW PHARMACEUTICAL TECHNOLOGY on May 27 for "Composition and method for treatment of diabetes" (Chinese Inventor)

ALEXANDRIA, Va., June 17 -- United States Patent no. 12,310,985, issued on May 27, was assigned to SHENZHEN PROFOUND VIEW PHARMACEUTICAL TECHNOLOGY (Shenzhen, China).

"Composition and method for treatment of diabetes" was invented by Taolei Sun (Wuhan, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are a pharmaceutical use of a gold cluster for the treatment of diabetes in a subject. The gold cluster comprises a gold core and a ligand modifying the gold core."

The patent was filed on Oct. 15, 2020, under Application No. 17/753,307.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%...